Pure Global

“Bard” Glidepath Long-Term Hemodialysis Catheter - Taiwan Registration d77ec6c5f11dd26cc0d0c2931f67daf1

Access comprehensive regulatory information for “Bard” Glidepath Long-Term Hemodialysis Catheter in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number d77ec6c5f11dd26cc0d0c2931f67daf1 and manufactured by BARD ACCESS SYSTEMS, INC.. The authorized representative in Taiwan is BARD PACIFIC HEALTH CARE CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
d77ec6c5f11dd26cc0d0c2931f67daf1
Registration Details
Taiwan FDA Registration: d77ec6c5f11dd26cc0d0c2931f67daf1
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

“Bard” Glidepath Long-Term Hemodialysis Catheter
TW: “巴德”葛萊帕斯長期性血液透析導管
Risk Class 3
MD

Registration Details

d77ec6c5f11dd26cc0d0c2931f67daf1

Ministry of Health Medical Device Import No. 033814

DHA05603381403

Company Information

United States

Product Details

For details, it is Chinese approved copy of the imitation order

H Gastroenterology-urology devices

H5540 Blood access devices and accessories

Imported from abroad

Dates and Status

Jul 25, 2020

Jul 25, 2025